Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease

BACKGROUND: Mirtazapine, a noradrenergic and specific serotonergic antidepressant (NaSSA), shows multiple pharmacological actions such as inhibiting presynaptic α(2) noradrenaline receptor (NAR) and selectively activating 5-hydroxytriptamine (5-HT) 1A receptor (5-HT(1A)R). Mirtazapine was also repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadoguchi, Naoto, Okabe, Shinji, Yamamura, Yukio, Shono, Misaki, Fukano, Tatsuya, Tanabe, Akie, Yokoyama, Hironori, Kasahara, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076436/
https://www.ncbi.nlm.nih.gov/pubmed/24965042
http://dx.doi.org/10.1186/1471-2202-15-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076436/
https://www.ncbi.nlm.nih.gov/pubmed/24965042
http://dx.doi.org/10.1186/1471-2202-15-79

Ejemplares similares